glp 1 weight loss shot Another Weight-Loss Trial Win for Weekly GLP-1 Drug Benefits of Semaglutide GLP-1 Injections
Description
Nutr Today

Welle S, Campbell RG
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
Staff TAP: New Findings Suggest No Correlation Between GLP1 Receptor Agonists and Thyroid Cancer Risk, The ASCO Post, 2024

Sinus infections and the common cold are good examples

However, up to 89% of participants taking efinopegdutide experienced gastrointestinal adverse events (mostly nausea, vomiting and diarrhoea) relative to 28% taking placebo and 60% taking liraglutide (86)

Real-world studies suggest gastrointestinal side effects particularly nausea and digestive discomfort are among the leading reasons people stop treatment, alongside cost
